SCHEMBL14927583

SCHEMBL14927583

CC(C)(C)OC(=O)N[C@H]1CCCC[C@H]1Nc1nc(Cl)c(C(N)=O)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 10/20 0.49
ROCK2 O75116 2/20 0.42
ROCK1 Q13464 2/20 0.42
HDAC4 P56524 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
PARP1 P09874 2/20 0.40
FER P16591 1/20 0.36
MAPK8 P45983 1/20 0.36
JAK2 O60674 3/20 0.36
MAP4K4 O95819 1/20 0.36
HCK P08631 1/20 0.36
ROS1 P08922 1/20 0.36
PIM1 P11309 1/20 0.36
PRKACA P17612 1/20 0.36
MARK3 P27448 1/20 0.36
LTK P29376 1/20 0.36
FLT3 P36888 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CLK2 P49760 1/20 0.36
MAPK10 P53779 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14910268 1.00 SYK (0.49) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL14910267 1.00 SYK (0.49) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL14909358 0.91 SYK (0.42) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL14909359 0.91 SYK (0.42) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL14927551 0.91 SYK (0.42) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL14927559 0.90 SYK (0.42) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL14910843 0.90 SYK (0.42) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL14910841 0.90 SYK (0.42) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL17841735 0.86 SYK (0.40) SYKROCK2ROCK1HDAC4HDAC6
SCHEMBL16169368 0.83 SYK (0.57) SYKROCK2ROCK1FERJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK SYK 1/4885ROCK2 1485/4885ROCK1 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.